Amneal Pharmaceuticals Competitors and Similar CompaniesClear all
Amneal Pharmaceuticals's competitors and similar companies include Shionogi, Sagent Pharmaceuticals and Sun Pharma.
 Amneal Pharmaceuticals Amneal Pharmaceuticals is a company engaged in the development, manufacturing, and distribution of generic and specialty pharmaceutical products. |  Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  Sagent Pharmaceuticals Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products. |  Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company. | |
Founding Date | Founding Date 2002 | Founding Date 1878 | Founding Date 2006 | Founding Date 1983 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Bridgewater Township, US HQ Gröbenzell, DE Ahmedabad, IN Ahmedabad, IN Ahmedabad, IN Dahej, IN Mahabubnagar, IN see more | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Schaumburg, US HQ | Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more |
Employees | Employees 8,1005% increase | Employees 4,955 | Employees 2261% increase | Employees 43,000 |
Valuation ($) | Valuation ($) 2.6 b | Valuation ($) 12.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $3b (FY, 2025) | Revenue (est.) ¥499.7b (FY, 2026) | Revenue (est.) $318.3m (FY, 2015) | Revenue (est.) ₹582.2b (FY, 2026) |
Cost of goods | Cost of goods $1.9b (FY, 2025) | Cost of goods ¥62.1b (FY, 2026) | Cost of goods $230.6m (FY, 2015) | Cost of goods ₹115.4b (FY, 2026) |
Gross profit | Gross profit $1.1b (FY, 2025) | Gross profit ¥484.8b (FY, 2026) | Gross profit $87.7m (FY, 2015) | Gross profit ₹488.9b (FY, 2026) |
Net income | Net income $127.9m (FY, 2025) | Net income ¥205.9b (FY, 2026) | Net income ($21.9m) (FY, 2015) | Net income ₹115.6b (FY, 2026) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 4.7m | Total funding raised $ 70m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Shionogi
HQ
Osaka, JP
Employees
4,955
Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
View companySagent Pharmaceuticals
HQ
Schaumburg, US
Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products.
View companySun Pharma
HQ
Mumbai, IN
Employees
43,000
Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
View company